Statera Biopharma Inc. (STAB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 0 | $0 | -100% | 0% |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.42 | 1,891 | Director | 6,116 | 2015-02-25 | Filing | |
| $1.61 | 6,210 | Director | 31,866 | 2013-05-21 | Filing | |
| $1.60 | 3,500 | Director | 84,500 | 2013-05-17 | Filing | |
| $1.56 | 3,700 | Director | 8,000 | 2013-03-15 | Filing | |
| $1.35 | 4,300 | Director | 4,300 | 2012-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.94 | 20,000 | Officer, Director | 1,168,400 | 2012-03-20 | Filing | |
| $3.04 | 35,601 | Officer, Director | 1,188,400 | 2012-03-19 | Filing | |
| $3.12 | 44,399 | Officer, Director | 1,224,001 | 2012-03-16 | Filing | |
| $3.53 | 200 | Officer, Director | 1,504,600 | 2010-05-17 | Filing | |
| $3.56 | 100 | Officer, Director | 1,504,800 | 2010-05-17 | Filing |
Institutional Investors' Holdings
Billionaire Hedge Funds
